SYNTHETIC COPOLYMER-1 AND MYELIN BASIC-PROTEIN DO NOT REQUIRE PROCESSING PRIOR TO BINDING TO CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES ON LIVING ANTIGEN-PRESENTING CELLS

被引:33
作者
FRIDKISHARELI, M
TEITELBAUM, D
ARNON, R
SELA, M
机构
[1] Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot
关键词
D O I
10.1006/cimm.1995.1121
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the present study we attempted to examine whether copolymer 1 (Cop 1), a synthetic basic random copolymer of amino acids (a candidate drug for multiple sclerosis (MS)), and myelin basic protein (MBP) undergo processing prior to their binding to MHC class II molecules on antigen-presenting cells (APC). The direct binding of biotinylated Cop 1 and MBP to living APC was monitored by flow cytometry using phycoerythrin (PE)-streptavidin, The time course for either Cop 1 or MBP binding was similar at 37 degrees C and on ice. Both Cop 1 and MBP bound to glutaraldehyde-fixed APC. Furthermore, these biotinylated antigens bound also in the presence of protease inhibitors and lysosomotropic agents, suggesting that proteolysis is not required prior to their interaction with the MHC determinants. Finally, short fragments of Cop 1 molecule did not bind to most of the APC, suggesting that the polymeric nature of Cop 1 is important for its efficient and promiscuous binding. (C) 1995 Academic Press, Inc.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 55 条
  • [1] COMPETITION FOR ANTIGEN PRESENTATION IN LIVING CELLS INVOLVES EXCHANGE OF PEPTIDES BOUND BY CLASS-II MHC MOLECULES
    ADORINI, L
    APPELLA, E
    DORIA, G
    CARDINAUX, F
    NAGY, ZA
    [J]. NATURE, 1989, 342 (6251) : 800 - 803
  • [2] T-SUPPRESSOR HYBRIDOMAS AND INTERLEUKIN-2-DEPENDENT LINES INDUCED BY COPOLYMER-1 OR BY SPINAL-CORD HOMOGENATE DOWN-REGULATE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    AHARONI, R
    TEITELBAUM, D
    ARNON, R
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) : 17 - 25
  • [3] ALLEN PM, 1984, J IMMUNOL, V132, P1077
  • [4] STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 506 - 512
  • [5] INVITRO SYNTHESIS OF ANTIBODIES TO ACETYLCHOLINE-RECEPTOR BY EPSTEIN-BARR VIRUS-STIMULATED LYMPHOCYTES-B DERIVED FROM PATIENTS WITH MYASTHENIA-GRAVIS
    BRENNER, T
    TIMORE, Y
    WIRGUIN, I
    ABRAMSKY, O
    STEINITZ, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1989, 24 (03) : 217 - 222
  • [6] BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707
  • [7] 3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1
    BROWN, JH
    JARDETZKY, TS
    GORGA, JC
    STERN, LJ
    URBAN, RG
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1993, 364 (6432) : 33 - 39
  • [8] DEGENERATE BINDING OF IMMUNOGENIC PEPTIDES TO HLA-DR PROTEINS ON B-CELL SURFACES
    BUSCH, R
    STRANG, G
    HOWLAND, K
    ROTHBARD, JB
    [J]. INTERNATIONAL IMMUNOLOGY, 1990, 2 (05) : 443 - 451
  • [9] THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES
    BUUS, S
    SETTE, A
    COLON, SM
    MILES, C
    GREY, HM
    [J]. SCIENCE, 1987, 235 (4794) : 1353 - 1358
  • [10] CHAIN BM, 1986, IMMUNOLOGY, V58, P271